Breast Cancer Home > Pergeta

Were you looking for information about Perjeta? Pergeta is a common misspelling of Perjeta.
As a type of biologic therapy, Perjeta™ (pertuzumab) may help in the treatment of certain types of breast cancer. The drug is specifically approved for use in adults and must be used in combination with certain other medications.
Perjeta is given as an intravenous infusion that is administered by a healthcare provider every three weeks. Although most people tolerate the medicine well, side effects (such as fatigue, diarrhea, and nausea) may occur.
(Click Perjeta for more information on what this medication is used for, dosing guidelines, and what your healthcare provider needs to know before you start treatment. You can also click any of the links in the box to the right for specific information.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.